Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP794887.RA6KglovW_HuA1lCJmcq_gJvNN4JmDofeSzgaAsVyOctM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP794887.RA6KglovW_HuA1lCJmcq_gJvNN4JmDofeSzgaAsVyOctM130_assertion type Assertion NP794887.RA6KglovW_HuA1lCJmcq_gJvNN4JmDofeSzgaAsVyOctM130_head.
- NP794887.RA6KglovW_HuA1lCJmcq_gJvNN4JmDofeSzgaAsVyOctM130_assertion description "[These findings may have important implications for the use of GM-CSF-G250 FP as a tumor vaccine for the treatment of patients with advanced kidney cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP794887.RA6KglovW_HuA1lCJmcq_gJvNN4JmDofeSzgaAsVyOctM130_provenance.
- NP794887.RA6KglovW_HuA1lCJmcq_gJvNN4JmDofeSzgaAsVyOctM130_assertion evidence source_evidence_literature NP794887.RA6KglovW_HuA1lCJmcq_gJvNN4JmDofeSzgaAsVyOctM130_provenance.
- NP794887.RA6KglovW_HuA1lCJmcq_gJvNN4JmDofeSzgaAsVyOctM130_assertion SIO_000772 11691814 NP794887.RA6KglovW_HuA1lCJmcq_gJvNN4JmDofeSzgaAsVyOctM130_provenance.
- NP794887.RA6KglovW_HuA1lCJmcq_gJvNN4JmDofeSzgaAsVyOctM130_assertion wasDerivedFrom befree-20140225 NP794887.RA6KglovW_HuA1lCJmcq_gJvNN4JmDofeSzgaAsVyOctM130_provenance.
- NP794887.RA6KglovW_HuA1lCJmcq_gJvNN4JmDofeSzgaAsVyOctM130_assertion wasGeneratedBy ECO_0000203 NP794887.RA6KglovW_HuA1lCJmcq_gJvNN4JmDofeSzgaAsVyOctM130_provenance.